TickerFacts.

Ceribell, Inc. (CBLL): Gross Profit

Annual figures by period end, from SEC filings.

$78.27M
Year ended 2025-12-31
$90.64M
Trailing 12 months to 2026-06-30
2023-12-31: $38.16M2024-12-31: $56.75M2025-12-31: $78.27M$78.27M
2023-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$78.27M+37.9%2026-02-24, From 2025-01-01
2024-12-31$56.75M+48.7%2026-02-24, From 2024-01-01
2023-12-31$38.16Mn/a2025-02-25, From 2023-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Ceribell, Inc. (CBLL)2025-12-31$78.27M+37.9%
Vaso Corp (VASO)2025-12-31$54.67M+5.0%
Biolife Solutions Inc (BLFS)2025-12-31$62.12M+24.0%
Electromed, Inc. (ELMD)2026-06-30$57.94M+16.0%
Outset Medical, Inc. (OM)2025-12-31$46.75M+21.2%
Iridex Corp (IRIX)2026-01-03$19.23M-1.4%
Axogen, Inc. (AXGN)2025-12-31$167.35M+17.9%
Stereotaxis, Inc. (STXS)2025-12-31$17.07M+17.0%
electroCore, Inc. (ECOR)2025-12-31$27.79M+29.9%

Compare CBLL, VASO, BLFS, ELMD side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗